fig1

MAFLD under the lens: the role of gut microbiota

Figure 1. Step-by-step acquisition of unhealthy patterns of gut dysbiosis with the severity of liver disease in patients with MAFLD. TMAO: Trimethylamine-N-oxide; MAFLD: metabolic-associated fatty liver disease; HCC: hepatocellular carcinoma; LPS: lipopolysaccharides; SCFA: short-chain fatty acids.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/